Literature DB >> 8104817

Uptake of drugs and expression of P-glycoprotein in the rat 9L glioma.

T Yamashima1, T Ohnishi, Y Nakajima, T Terasaki, M Tanaka, J Yamashita, T Sasaki, A Tsuji.   

Abstract

Two weeks after the inoculation of 1.5 x 10(5) 9L glioma cells into the rat brain, the uptake of radiolabelled drugs into the brain and the experimental 9L glioma during the first cerebral circulation was measured with a liquid scintillation counter and analyzed by the method of Oldendorf (1970). The expression of P-glycoprotein, which is known to be associated with the efflux of drugs, was also studied, using anti-P-glycoprotein monoclonal antibody, C-219. Furthermore, the ultrastructure of brain capillaries, tumor vessels, and glioma cells was studied by conventional and immunoelectron microscopy. Sucrose (control), the transport of which through the blood-brain barrier is known to be negligible, accumulated to fivefold higher levels in the tumor than in normal brain. Ranimustine (MCNU), 5-fluorouracil (5-FU), and doxorubicin showed little accumulation in the normal brain, whereas nimustine (ACNU) showed an increased accumulation. MCNU and doxorubicin showed negligible accumulation in the glioma cells despite diffusion into the tumor interstitial space. In contrast, ACNU and 5-FU showed an increased accumulation in tumor cells. The accumulation of 5-FU in the cultured 9L glioma cells was decreased by ATP inhibitors or by low temperature. Although both brain capillary endothelial cells and glioma cell membrane were immunohistochemically positive for P-glycoprotein, the tumor vasculature showed low expression of P-glycoprotein. The endothelial cells of tumor vessels ultrastructurally showed increased fenestrations, swelling, and disrupted junctions. Accordingly, it is suggested that hydrophobic drugs such as doxorubicin, being pumped out by P-glycoprotein, do not accumulate in 9L glioma cells as do other lipophilic drugs such as ACNU, or drugs such as 5-FU, which accumulate by a carrier-mediated mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8104817     DOI: 10.1007/bf00229652

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  33 in total

1.  Chemotherapy of brain tumors.

Authors:  N A Vick; J D Khandekar; D D Bigner
Journal:  Arch Neurol       Date:  1977-09

2.  Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  J Histochem Cytochem       Date:  1989-02       Impact factor: 2.479

3.  Uptake of benzylpenicillin, cefpiramide and cefazolin by freshly prepared rat hepatocytes. Evidence for a carrier-mediated transport system.

Authors:  A Tsuji; T Terasaki; K Takanosu; I Tamai; E Nakashima
Journal:  Biochem Pharmacol       Date:  1986-01-15       Impact factor: 5.858

4.  A mechanism underlying the lack of a blood-brain barrier to peroxidase in virally induced brain tumors.

Authors:  M W Brightman; T S Reese; N A Vick; D D Bigner
Journal:  J Neuropathol Exp Neurol       Date:  1971-01       Impact factor: 3.685

5.  Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.

Authors:  I Sugawara; I Kataoka; Y Morishita; H Hamada; T Tsuruo; S Itoyama; S Mori
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

6.  Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines.

Authors:  J R Riordan; K Deuchars; N Kartner; N Alon; J Trent; V Ling
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

7.  Differential effect of plasma protein binding of bupivacaine on its in vivo transfer into the brain and salivary gland of rats.

Authors:  T Terasaki; W M Pardridge; D D Denson
Journal:  J Pharmacol Exp Ther       Date:  1986-12       Impact factor: 4.030

8.  Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

Authors:  R F Ozols; R E Cunnion; R W Klecker; T C Hamilton; Y Ostchega; J E Parrillo; R C Young
Journal:  J Clin Oncol       Date:  1987-04       Impact factor: 44.544

9.  Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration.

Authors:  G D Pennock; W S Dalton; W R Roeske; C P Appleton; K Mosley; P Plezia; T P Miller; S E Salmon
Journal:  J Natl Cancer Inst       Date:  1991-01-16       Impact factor: 13.506

10.  Biologic activity of MCNU: a new antitumor agent.

Authors:  S Sekido; K Ninomiya; M Iwasaki
Journal:  Cancer Treat Rep       Date:  1979-06
View more
  4 in total

1.  Liposome-mediated therapy of intracranial brain tumors in a rat model.

Authors:  U S Sharma; A Sharma; R I Chau; R M Straubinger
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

2.  Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres.

Authors:  Patrik Gabikian; Betty M Tyler; Irma Zhang; Khan W Li; Henry Brem; Kevin A Walter
Journal:  J Neurosurg       Date:  2014-03-07       Impact factor: 5.115

3.  Ultrasound-Induced hyperthermia increases cellular uptake and cytotoxicity of P-glycoprotein substrates in multi-drug resistant cells.

Authors:  Y Liu; C W Cho; X Yan; T K Henthorn; K O Lillehei; W N Cobb; K Y Ng
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

4.  Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes.

Authors:  Sabine Spiegl-Kreinecker; Johanna Buchroithner; Leonilla Elbling; Elisabeth Steiner; Gabriele Wurm; Angelika Bodenteich; Johannes Fischer; Michael Micksche; Walter Berger
Journal:  J Neurooncol       Date:  2002-03       Impact factor: 4.130

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.